IP Library › Assignment 017636/0951
Patent Assignment
Reel/Frame 017636/0951

Release of Security Interest

Recorded: 2006-02-24 Pages: 20
Assignors
PILON-CLAYTON, APRILE L.
Executed: 2005-08-03
ASM RESOURCES, INC.
Executed: 2005-10-06
SILVEIRA, KIM
Executed: 2005-08-03
SILVERIA, BRAD
Executed: 2005-08-03
DWYER, PATRICK
Executed: 2005-10-06
DWYER, CHERYL
Executed: 2005-10-06
MARYLAND ANGELS COUNSEL, LLC
Executed: 2005-08-03
WOMENANGELS.NET, LLC
Executed: 2005-10-31
Assignee
CLARAGEN, INC.
P.O. BOX 2225, GAITHERSBURG, MARYLAND, 20875
Covered Properties (10)
Use of Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions
Patent: 6,255,281 →
Application: 08/864,357 →
Use of Recombinant Human Uterogobin in Treatment of Inflammtory and Fibrotic Conditions
Application: 09/087,210 →
Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions
Application: 09/120,264 →
Publication: US 2002/0160948
Methods and compositions for the treatment of fibrotic conditions & impaired lung functionn & to enhance lymphocyte production
Application: 09/549,926 →
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
Application: 09/835,784 →
Publication: US 2003/0008816
Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Application: 09/861,688 →
Publication: US 2002/0173460
Methods for the Production of Purified Recombinant Human Uteroglobin for the Treatment of Inflammatory and Fibrotic Conditions
Patent: 7,122,344 →
Application: 09/898,616 →
Publication: US 2003/0109429
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
Application: 10/045,534 →
Publication: US 2002/0169108
Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
Application: 10/187,498 →
Publication: US 2003/0207795
Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Application: 10/638,448 →
Publication: US 2005/0261180
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 26, 1997
From: PILON, APRILE L.
To: CLARAGEN, INC.
Reel/Frame 008728/0633 →
Assignment of Assignor's Interest Nov 20, 1997
From: MUKHERJEE, ANIL B.; ZHANG, ZHONGJIAN
To: HEALTH & HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH, UNITED STATES GOVERNMENT
Reel/Frame 008799/0943 →
Assignment of Assignor's Interest Aug 31, 1998
From: MUKHERJEE, ANIL B.; ZHANG, ZHONGJIAN; PILON, APRILE L.
To: NATIONAL INSTITUTES OF HEALTH; CLARAGEN, INC.
Reel/Frame 009440/0127 →
Assignment of Assignor's Interest Oct 5, 1998
From: MUCHERJEE, ANIL B.; ZHANG, ZHONGJIAN; PILON, APRILE L.
To: NATIONAL INSTITUTE OF HEALTH; CLARAGEN, INC.
Reel/Frame 009499/0145 →
Assignment of Assignor's Interest Jan 9, 2002
From: PILON, APRILE L.; WELCH, RICHARD; FARROW, JEFFREY; MELBY, JAMES
To: CLARAGEN, INC.
Reel/Frame 012445/0021 →
Assignment of Assignor's Interest Mar 1, 2002
From: PILON, APRILE L.; WELCH, RICHARD
To: CLARAGEN, INC.
Reel/Frame 012658/0543 →
Security Interest Jan 7, 2004
From: CLARAGEN, INC.
To: MARYLAND ANGELS COUNSEL, LLC ("MAC"); WOMENANGELS.NET, LLC
Reel/Frame 014861/0633 →
Security Agreement Jan 26, 2004
From: CLARAGEN, INC.
To: PILON, APRILE; MARYLAND HEALTH CARE PRODUCT DEVELOPMENT CORPORATION; GALLOWAY, WILLIAM R, AS TRUSTEE OF WILLIAM R. GALLOWAY TTEE U/A DTD 08/06/1998; WILLIAMS, RICHARD O., AS TRUSTEE OF RICHARD O. WILLIAMS REVOCABLE TRUST U/A/D FEBRUARY 28, 1996
Reel/Frame 015740/0858 →
Assignment of Assignor's Interest Sep 2, 2004
From: CLARAGEN, INC.
To: APRILE PILON; MARYLAND HEALTH CARE PRODUCT DEVELOPMENT CORPORATION; GALLOWAY, WILLIAM R. AS TRUSTEE OF WILLIAM R. GALLOWAY TTEE U/A DTD 08/061998; WILLIAMS, RICHARD O. AS TRUSTEE OF RICHARD O. WILLI
Reel/Frame 015748/0278 →
Corrective Security Interest to Delete U.S. Patent No. 6,599,031 and 6,436,619, Previously Recorded at Reel 14861 Frame 633. Apr 1, 2005
From: CLARAGEN, INC.
To: MARYLAND ANGELS COUNSEL, LLC ("MAC"); WOMENANGELS.NET, LLC
Reel/Frame 016429/0058 →
Assignment of Assignor's Interest Oct 25, 2007
From: CLARAGEN INC.
To: CC10 SWEDEN AB
Reel/Frame 020010/0479 →
Assignment of Assignor's Interest May 3, 2010
From: CC10 SWEDEN AB
To: CLARASSANCE, INC.
Reel/Frame 024320/0417 →
Assignment of Assignor's Interest May 3, 2010
From: CC10 SWEDEN AB
To: CLARASSANCE, INC.
Reel/Frame 024320/0397 →
Change of Name Apr 3, 2015
From: CLARASSANCE INC.
To: THERABRON THERAPEUTICS INC.
Reel/Frame 035365/0889 →